The gov­ern­ment on Tues­day an­nounced fi­nal prices for the sec­ond round of drugs ne­go­ti­at­ed by Medicare un­der the In­fla­tion Re­duc­tion Act, in­clud­ing for No­vo Nordisk’s block­buster semaglu­tide prod­ucts Ozem­pic and We­govy...